EP Patent

EP0998304A1 — Pharmaceutical compositions comprising cyclodextrins

Assigned to Janssen Pharmaceutica NV · Expires 2000-05-10 · 26y expired

What this patent protects

The invention provides a novel pharmaceutical composition comprising a no more than sparingly water-soluble drug compound, a cyclodextrin, a physiologically tolerable water-soluble acid, and a physiologically tolerable water-soluble organic polymer.

USPTO Abstract

The invention provides a novel pharmaceutical composition comprising a no more than sparingly water-soluble drug compound, a cyclodextrin, a physiologically tolerable water-soluble acid, and a physiologically tolerable water-soluble organic polymer.

Drugs covered by this patent

olopatadine-hydrochloride (OLOPATADINE HYDROCHLORIDE)

Patent Metadata

Patent number: EP0998304A1
Jurisdiction: EP
Classification: —
Expires: 2000-05-10
Drug substance claim: No
Drug product claim: No
Assignee: Janssen Pharmaceutica NV
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.